- Home
- NNI vs VKTX Comparison
NNI vs VKTX Comparison
Compare NNI & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNI
- VKTX
- Stock Information
- Founded
- NNI 1978
- VKTX 2012
- Country
- NNI United States
- VKTX United States
- Employees
- NNI N/A
- VKTX N/A
- Industry
- NNI Finance: Consumer Services
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- NNI Finance
- VKTX Health Care
- Exchange
- NNI Nasdaq
- VKTX Nasdaq
- Market Cap
- NNI 4.2B
- VKTX 3.5B
- IPO Year
- NNI 2003
- VKTX 2015
- Fundamental
- Price
- NNI $122.37
- VKTX $33.50
- Analyst Decision
- NNI Hold
- VKTX Strong Buy
- Analyst Count
- NNI 1
- VKTX 13
- Target Price
- NNI $98.00
- VKTX $86.92
- AVG Volume (30 Days)
- NNI 101.3K
- VKTX 4.1M
- Earning Date
- NNI 08-06-2025
- VKTX 07-23-2025
- Dividend Yield
- NNI 0.92%
- VKTX N/A
- EPS Growth
- NNI 44.75
- VKTX N/A
- EPS
- NNI 5.30
- VKTX N/A
- Revenue
- NNI $1,365,360,000.00
- VKTX N/A
- Revenue This Year
- NNI $14.91
- VKTX N/A
- Revenue Next Year
- NNI $5.52
- VKTX N/A
- P/E Ratio
- NNI $23.07
- VKTX N/A
- Revenue Growth
- NNI 9.48
- VKTX N/A
- 52 Week Low
- NNI $98.15
- VKTX $18.92
- 52 Week High
- NNI $127.32
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- NNI 59.22
- VKTX 70.14
- Support Level
- NNI $119.28
- VKTX $31.63
- Resistance Level
- NNI $122.59
- VKTX $33.61
- Average True Range (ATR)
- NNI 2.33
- VKTX 1.73
- MACD
- NNI -0.30
- VKTX 0.29
- Stochastic Oscillator
- NNI 51.93
- VKTX 84.56
About NNI Nelnet Inc.
Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.